Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
NEOGEN CORP (NEOG) director Rafael A. Rodriguez received 2,071 restricted stock units that vested and were settled into 2,071 shares of common stock on 10/07/2025. The reported per-share value on the transaction is $5.63, and Mr. Rodriguez's total beneficial ownership after the settlement is 17,019 shares held directly. The filing is a Form 4 disclosure of an insider vesting event rather than a market purchase or sale.
Ashima Gupta, a director of Neogen Corporation (NEOG), reported the vesting and settlement of 2,071 restricted stock units (RSUs) into 2,071 shares of common stock on 10/07/2025. The reported per‑share value recorded on the form is $5.63, and the reporting form shows 23,988 shares beneficially owned by the reporting person following this transaction.
The filing is a routine Section 16 disclosure showing compensation‑related equity vesting rather than an open‑market buy or sell. The form was signed by an attorney‑in‑fact on 10/09/2025.
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.
Jeffrey D. Capello, a director of Neogen Corporation (NEOG), had 2,071 restricted stock units vest and settle on 10/07/2025.
The settlement converted the RSUs into 2,071 shares of common stock at an indicated unit price of $5.63, bringing his total beneficial ownership to 28,700 shares following the transaction.
Insider report: A director of Neogen Corporation (NEOG) had 2,071 restricted stock units vest and be settled for 2,071 shares of common stock on 10/07/2025. The transaction is recorded as a vesting/settlement (code M) with an indicated price of $5.63 per share. After the settlement the reporting person beneficially owned 92,545 shares. The Form 4 was signed on 10/09/2025.
William T. Boehm, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of Common Stock on 10/07/2025 at a reported per‑share value of $5.63. After the transaction Mr. Boehm beneficially owns 38,285 shares directly. The Form 4 was signed by an attorney‑in‑fact on 10/09/2025.
Neogen Corp (NEOG) reported transactional and control updates for the quarter ended August 31, 2025. The company recognized a $76,390 gain on the sale of a business, received $121,724 in cash at closing (net of cash divested) and may receive up to $3,500 in contingent earnout consideration tied to 12 months of post‑closing revenue performance. The company made debt actions including $51,500 of principal activity on a Revolving Facility, $45,000 of prepayments on the Term Loan (generating a $393 extinguishment loss) and repurchased $3,500 million of Senior Notes (generating a $41 extinguishment loss). Management is strengthening internal controls, hiring dedicated control personnel, implementing document retention, and providing COSO framework training. The filing notes potential impacts from the Pillar Two global minimum tax rules and a forecasted top‑up tax mechanism, but no material top‑up tax was forecasted for foreign subsidiaries for the quarter.
Neogen Corporation filed a current report to note that it has released financial results for its fiscal 2026 first quarter, which ended on August 31, 2025. The company issued a press release on October 9, 2025 summarizing its operations and financial condition for that quarter, and attached this release as an exhibit to the report. The filing clarifies that the press release is being furnished, rather than filed, under securities laws, which affects how it is treated for certain legal and liability purposes.
Neogen Corporation reported that its Chief Financial Officer and Chief Operating Officer, David Naemura, has informed the company of his intention to resign to pursue other opportunities. The company stated that his decision is not related to any disagreement over operations, financial statements, accounting policies, or internal controls. He will continue in his current roles until a departure date expected between the filing of Neogen’s October Form 10-Q and the end of the calendar year, helping ensure continuity.
The board’s Compensation and Talent Management Committee determined it is in the company’s and shareholders’ best interests for Naemura to assist with onboarding a new Chief Financial Officer. Under a transition agreement, if he remains employed through December 31, 2025, he will be eligible, in addition to his base pay, to receive 50% of his annual target cash bonus under Neogen’s annual incentive plan. Neogen also issued a press release announcing his resignation.
The filing describes how certain executive Performance Stock Units (PSUs) will be settled after the end of the Performance Period. An independent committee will compare the Companys actual performance to the pre-established metrics and apply an rTSR multiplier to determine how many PSUs, if any, are earned. Any earned PSUs will be converted into shares of the Companys common stock and issued to the named executive officer as soon as practicable, and those shares will be fully vested upon issuance. Until settlement, the PSUs do not give the executives any ownership interest or shareholder rights.